MyFinsight
Home
Blog
About
Back
Income Statement
Corvus Pharmaceuticals, Inc. (CRVS)
Corvus Pharmaceuticals, Inc. (CRVS)
source: myfinsight.com
Comprehensive (gain) income
-$18,126K
(-129.68%↓ Y/Y)
Cumulative foreign
currency translation...
$320K
(156.00%↑ Y/Y)
Net (gain) income
-$17,959K
(-124.54%↓ Y/Y)
Unrealized loss on
marketable securities
-$487K
(-2463.16%↓ Y/Y)
Income (gain) before
equity method...
-$17,250K
(-126.71%↓ Y/Y)
Loss from equity
method investment
-$709K
(-82.26%↓ Y/Y)
Interest income and other
expense, net
$2,047K
(220.34%↑ Y/Y)
Loss from operations
-$19,297K
(-88.08%↓ Y/Y)
Total operating
expenses
$19,297K
(88.08%↑ Y/Y)
Research and development
$15,964K
(102.77%↑ Y/Y)
General and
administrative
$3,333K
(39.63%↑ Y/Y)
Back